Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

Kee‐Taek Jang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7987-4437; OpenAlex author ID A5027943858. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 15

  1. Artificial Intelligence-Powered Spatial Analysis of Immune Phenotypes in Resected Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2025.1999↗
  2. L-Ascorbic acid preferentially kills KRAS mutant pancreatic cancer cells through DNA damage. Co-author DOI 10.1038/s41598-025-07668-1↗
  3. Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adeno… Co-author DOI 10.1016/j.gie.2024.02.021↗
  4. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma an… Co-author DOI 10.1186/s12943-024-02003-0↗
  5. Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma: Recommendations From the Pancreatobiliary Pathology Socie… Co-author DOI 10.1097/pas.0000000000001853↗
  6. Towards a More Standardized Approach to Pathologic Reporting of Pancreatoduodenectomy Specimens for Pancreatic Ductal Adenocarcinoma: Cross-continental and Cro… Co-author DOI 10.1097/pas.0000000000001723↗
  7. Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle Biopsy. Co-author DOI 10.3390/cancers13112791↗
  8. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.5009/gnl19011↗
  9. Comparison of 22-gauge standard fine needle versus core biopsy needle for endoscopic ultrasound-guided sampling of suspected pancreatic cancer: a randomized cr… Co-author DOI 10.1080/00365521.2017.1390597↗
  10. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. Co-author DOI 10.18632/oncotarget.17463↗
  11. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs. Co-author DOI 10.1097/mpa.0000000000000346↗
  12. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings. Last author DOI 10.5754/hge11946↗
  13. Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. Co-author DOI 10.1097/coc.0b013e31821a83d7↗
  14. Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine. Co-author DOI 10.2217/pgs.12.82↗
  15. Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Co-author DOI 10.1158/1535-7163.mct-11-0269↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyu Taek Lee · 9 shared papers, 2012–2025 · strength 0.95
  2. Joo Kyung Park · 5 shared papers, 2020–2025 · strength 0.76
  3. Hye Min Kim · 4 shared papers, 2021–2025 · strength 0.65
  4. Jong Kyun Lee · 6 shared papers, 2012–2025 · strength 0.59
  5. Jin Ho Choi · 3 shared papers, 2024–2025 · strength 0.53
  6. Young Suk Park · 5 shared papers, 2011–2025 · strength 0.40
  7. Semin Lee · 2 shared papers, 2024 · strength 0.35
  8. Joon Oh Park · 4 shared papers, 2011–2025 · strength 0.35
  9. Seung Tae Kim · 3 shared papers, 2011–2025 · strength 0.32
  10. Dong Hyo Noh · 3 shared papers, 2018–2021 · strength 0.31
  11. Jong Kyun Lee · 3 shared papers, 2013–2024 · strength 0.30
  12. Hye-Lim Jang · 2 shared papers, 2011–2025 · strength 0.29
  13. Olca Baştürk · 2 shared papers, 2021–2022 · strength 0.27
  14. Deepti Dhall · 2 shared papers, 2021–2022 · strength 0.27
  15. Daniela S. Allende · 2 shared papers, 2021–2022 · strength 0.27
  16. Volkan N. Adsay · 2 shared papers, 2021–2022 · strength 0.27
  17. Grace Kim · 2 shared papers, 2021–2022 · strength 0.27
  18. Jiaqi Shi · 2 shared papers, 2021–2022 · strength 0.27
  19. Jung Yong Hong · 1 shared paper, 2025 · strength 0.27
  20. Jin Seok Heo · 2 shared papers, 2017–2025 · strength 0.24
  21. Juhee Cho · 2 shared papers, 2018–2020 · strength 0.20
  22. Kwang Hyuck Lee · 3 shared papers, 2015–2018 · strength 0.19
  23. So Jeong Yoon · 1 shared paper, 2025 · strength 0.18
  24. In Woong Han · 1 shared paper, 2025 · strength 0.18
  25. Kyunga Kim · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.